Two Diseases, One Dupixent: Inhibition of Two of the Key Drivers of Type 2 Inflammation in Asthma and COPD
Wes Sublett, MD | Chesapeake Bay Room
Product Theater Lunch – Sanofi Regeneron
October 25 @ 12:25 pm - 1:05 pm EDT
Two Diseases, One Dupixent: Inhibition of Two of the Key Drivers of Type 2 Inflammation in Asthma and COPD
Wes Sublett, MD | Chesapeake Bay Room